This includes the assessment of hormone receptor status (estrogen receptor (ER) and progesterone receptor (PR)), human epidermal growth factor receptor 2 (HER2) expression, ki-67proliferation index and tumor grade. This evidence concerns the gene PGR and neoplasm.